Brain wave test could revolutionize hearing checks for babies

NCT ID NCT07392164

Not yet recruiting Diagnosis Sponsor: Susan Scollie Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new prototype device that measures brain responses to speech sounds in infants. Researchers will compare brain responses between infants with normal hearing and those with hearing loss, both with and without hearing aids. The goal is to see if the device can accurately assess hearing, potentially leading to better and earlier hearing care for babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: prototype device for speech-evoked envelope following response measurement
What this could lead to: If successful, this device could provide a more objective way to assess hearing in infants, potentially improving early detection and management of hearing loss.
What could go wrong: This is a small, early-stage study with only 20 infants, so results may not apply broadly. The device is a prototype and may not be accurate enough for clinical use yet.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEARING IMPAIRMENT

Contacts and locations

Locations

Dalhousie University

Halifax, Nova Scotia, B3H4R2, Canada
National Acoustic Laborartory

Macquarie Park, Sydney, NSW 2113, Australia
National Centre for Audiology at Western University

London, Ontario, N6G1H1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.